Skip to main content
Premium Trial:

Request an Annual Quote

N-of-One Raises $7M in Series B Financing Round

NEW YORK (GenomeWeb) – N-of-One said today that it has raised $7 million in a Series B financing round from Providence Ventures and Excel Venture Management.

N-of-One said it plans to use the funds to expand its efforts to develop precision medicine-based clinical decision support solutions that provide physicians with a precise and scalable approach for matching patients to treatments and clinical trials. The proceeds will also be used to expand sales and marketing efforts in the US and other strategic global markets, the company said.

"This financing round marks a new and exciting chapter for N-of-One," CEO Chris Cournoyer said in a statement. "We look forward to collaborating with our lab and health system clients to incorporate clinical data along with the patient's molecular profile to provide further refinement of treatment options."

N-of-One has signed two deals this year — with Admera Health and Macrogen — to provide clinical interpretation services for patients tested with those companies' cancer panels. The firm also signed a deal with WuXi Nextcode in November 2015 to provide clinical and scientific evidence that supports personalized treatment recommendations made on the basis of WuXi's tumor-normal sequence interpretation.

The Scan

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.

Genome Biology Papers on GWAS Fine-Mapping Method, COVID-19 Susceptibility, Rheumatoid Arthritis

In Genome Biology this week: integrative fine-mapping approach, analysis of locus linked to COVID-19 susceptibility and severity, and more.